Cargando…

Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19

Understanding the course of the antibody response directed to individual epitopes of SARS-CoV-2 proteins is crucial for serological assays and establishment of vaccines. Twenty-one synthetic peptides were synthesized that have ten amino acids overlap and cover the complete membrane (M) protein. Plas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jörrißen, Philipp, Schütz, Paula, Weiand, Matthias, Vollenberg, Richard, Schrempf, Inga Marie, Ochs, Kevin, Frömmel, Christopher, Tepasse, Phil-Robin, Schmidt, Hartmut, Zibert, Andree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371319/ https://www.ncbi.nlm.nih.gov/pubmed/34421894 http://dx.doi.org/10.3389/fimmu.2021.679841

Ejemplares similares

Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
por: Varghese, Julian, et al.
Publicado: (2021)

Association of contact to small children with a mild course of COVID-19
por: Dugas, Martin, et al.
Publicado: (2020)

Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation
por: Weiand, Matthias, et al.
Publicado: (2022)

Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
por: Vollenberg, Richard, et al.
Publicado: (2021)

Prone Position in Mechanically Ventilated COVID-19 Patients: A Multicenter Study
por: Vollenberg, Richard, et al.
Publicado: (2021)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
por: Dugas, Martin, et al.
Publicado: (2021)

The Renin–Angiotensin System in COVID-19: Can Long COVID Be Predicted?
por: König, Simone, et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

The Dysregulation of the Renin–Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

High Angiotensin-Converting Enzyme and Low Carboxypeptidase N Serum Activity Correlate with Disease Severity in COVID-19 Patients
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

Reduced Vitamin A RBP Levels in Hospitalized COVID-19 Patients
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

Familial Mediterranean fever and COVID-19. An ancient disease in a pandemic of the new millennium: is it an epiphenomenon of infection?
por: Sensoy, Timur S, et al.
Publicado: (2021)

Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients
por: Vollenberg, Richard, et al.
Publicado: (2022)

Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study
por: Vollenberg, Richard, et al.
Publicado: (2022)

Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020
por: Wiegele, Patricia Nicole, et al.
Publicado: (2021)

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
por: Tepasse, Phil‐Robin, et al.
Publicado: (2020)

Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis
por: Bokemeyer, Arne, et al.
Publicado: (2023)

Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study
por: Rennebaum, Florian, et al.
Publicado: (2023)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients
por: Fahad, Ahmed S., et al.
Publicado: (2021)

Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever
por: Boeckel, Göran Ramin, et al.
Publicado: (2022)

ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells
por: Guttmann, Sarah, et al.
Publicado: (2020)

Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
por: Fuentes-Villalobos, Francisco, et al.
Publicado: (2022)

Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency
por: Condino-Neto, Antonio, et al.
Publicado: (2022)

Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
por: Vollenberg, Richard, et al.
Publicado: (2023)

Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series
por: Boeckel, Göran Ramin, et al.
Publicado: (2022)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
por: Dugas, Martin, et al.
Publicado: (2021)

Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human
por: Gao, Fei, et al.
Publicado: (2019)

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
por: Greenbaum, Uri, et al.
Publicado: (2021)

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
por: Curtò, Diego, et al.
Publicado: (2021)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
por: Rosati, Margherita, et al.
Publicado: (2021)

Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents
por: Wang, Zheng, et al.
Publicado: (2023)

Discrimination of COVID‐19 From Inflammation‐Induced Cytokine Storm Syndromes Using Disease‐Related Blood Biomarkers
por: Kessel, Christoph, et al.
Publicado: (2021)

Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0
por: Bidmos, Fadil A., et al.
Publicado: (2018)

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
por: Xiang, Tiandan, et al.
Publicado: (2021)

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience
por: Evers, Georg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_55kg8tgqv6mr6vfhi7t9dvv8er